Clarke, C., Flores-Muñoz, M., McKinney, C. A., Milligan, G. and Nicklin, S. A. (2013) Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin–angiotensin system. Future Cardiology, 9(1), pp. 23-38. (doi: 10.2217/fca.12.75)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.2217/fca.12.75
Abstract
The counter-regulatory axis of the renin–angiotensin system (RAS) is a novel therapeutic target in cardiovascular disease. Pathophysiological effects mediated via angiotensin II (Ang II) are well established in regulation of blood pressure, cardiac and vascular remodeling, and renal sodium handling, which lead to disorders such as hypertension and associated end-organ damage, atherosclerosis and heart failure. The counter-regulatory axis of the RAS is centered on the angiotensin-converting enzyme 2/angiotensin-1–7 (Ang-[1–7])/Mas receptor axis and has been shown to inhibit many detrimental phenotypes in cardiovascular disease. More recently, an alternative peptide, angiotensin-(1-9) (Ang-[1-9]), has been reported as a potential new member of this axis. This review will discuss the cardiovascular regulatory roles of Ang-(1–7) and Ang-(1–9) in the counter-regulatory axis of the RAS, and the potential for new therapeutic approaches in cardiovascular disease.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Nicklin, Professor Stuart and Clarke, Dr Carolyn and Milligan, Professor Graeme |
Authors: | Clarke, C., Flores-Muñoz, M., McKinney, C. A., Milligan, G., and Nicklin, S. A. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | Future Cardiology |
Publisher: | Future Medicine Ltd. |
ISSN: | 1479-6678 |
ISSN (Online): | 1744-8298 |
Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record